...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Newco Ownership

PVLee "Newco will be a wholly owned subsidiary of Zenith Capital Corp. The proposal for the Jan. Mtg doesn't mention anything about anybody getting shares in Newco. If you now own Zenith shares you'll still have the same shares and own everything Zenith owns now. I think the 34.4 is for now just a number."

It's not "just a number". Newco will be valued at 34.4 million shares x $1 US per share = $34.4 million. If that can morph into 103 million shares valued at $1 US per share = $103 million valuation, I'll be happy, but I don't see how.

Share
New Message
Please login to post a reply